Another study showed the therapeutic potential of lentinan in mouse models of IBD and CAC; lentinan exerts its beneficial effect in mice with IBD and CAC possibly by inhibiting TLR4/NF-κB signalling and the expression of colon cancer markers. The gene discussed is TLR4; the disease is inflammatory bowel disease.